21 November 2024 : Clinical Research
Decreased RSPO3 and β-Catenin in Preeclampsia: Correlation with Blood Pressure and Pregnancy Outcomes
Yunyun Liu1ABCDEF, Peishan Li1BCEF, Juan Liao1CD, Mingli Rao1BC, Ling Peng1C, Hua Gan1C, Lin Shang1C, Zhenghua Xiao1AG*, Xue Liu1AGDOI: 10.12659/MSM.945848
Med Sci Monit 2024; 30:e945848
Table 3 Adverse pregnancy outcomes of preeclampsia group and control group.
| Control (n=60) | Preeclampisa (n=60) | P value | |
|---|---|---|---|
| Cesarean delivery | 31 (51.7%) | 47 (78.3%) | 0.002 |
| Neonatal Intensive Care Unit | 2 (3.3%) | 18 (30.0%) | <0.001 |
| Low birth weight (<2500 g) | 1 (1.7%) | 15 (25.0%) | <0.001 |
| Stillbirth | 0 (0.0%) | 2 (3.3%) | <0.001 |
| Birth weight (g) | 2876.75±834.94 | 3379.22±365.86 | <0.001 |
| Birth length (cm) | 50.00 (49.00, 51.00) | 48.00 (44.25, 50.00) | <0.001 |
| 1-min Apgar score | 9.97±0.18 | 9.30±1.23 | <0.001 |
| 5-min Apgar score | 10.00±0.00 | 9.77±0.77 | 0.022 |
| 10-min Apgar score | 10.00±0.00 | 9.92±0.38 | 0.096 |
| Data that conform to normally distributed measurements are expressed as mean (±standard deviation) or numbers (%). Data that do not conform to the normally distributed measurements are expressed as quartiles. Pairwise comparison was analyzed using the Kruskal-Wallis test and test. Significant at | |||